Oxevision Sleep Device

by Oxehealth Limited (operating as LIO Health)  · Based in United Kingdom →Clinical foresight saves lives.
Psychiatry Pulmonology Sleep Medicine

£29,457 per ward per year
Regulatory Status Disclosed

Overview

The Oxevision Sleep Device, developed by Oxehealth Limited (now operating as LIO Health), is an advanced AI-powered activity monitor designed for contactless patient sleep assessment in healthcare environments. It is a software-only medical device (SaMD) that utilizes video footage from fixed-installation cameras within single-occupancy bed spaces to analyze patient movement, activity, and physiological sign data. The system provides a timeline of bed occupancy and sleep periods, automating the recognition of sleep and generating comprehensive sleep reports for healthcare professionals. This technology aims to enhance patient safety, improve care planning, and reduce the need for disruptive in-person observations, particularly in acute mental health settings, general care, and secured environments.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Contactless sleep assessment via video analysis
  • Analyzes activity, movement, and physiological signs during sleep
  • Provides timeline of bed occupancy and sleep periods
  • Automated recognition of sleep periods and report generation
  • Uses off-the-shelf cameras with infrared illumination
  • Secure access through tablets and nursing station screens
  • Automated activity reports for nighttime and daytime review
  • Exportable reports for integration into electronic patient records
  • Secure cloud and onsite data storage with AES-256bit encryption
  • Automated risk-based notifications and vital sign trend reports (part of broader Oxevision platform)

Use Cases

  • Monitoring sleep patterns in inpatient psychiatric settings
  • Enhancing patient safety in hospitals and secured environments
  • Reducing the need for disruptive in-person observations
  • Supporting clinical decision-making and care planning
  • Improving staff efficiency and freeing up time for therapeutic interactions
  • Reducing incidents of self-harm, assaults, and falls (as part of broader Oxevision platform)

What Physicians Need to Know

Crisis Detection & Escalation
The system provides automated risk-based notifications and alerts for various situations, including a patient being out of bed, spending prolonged time in the bathroom, being in a blind spot, or detecting no activity in an occupied room. It also alerts staff to a second person entering a room. These features aim to enable proactive intervention and reduce incidents like self-harm and falls.
PHQ-9/GAD-7 Integration
No information found regarding direct integration with PHQ-9 or GAD-7 scores. The system focuses on physiological and activity monitoring.
Session Note Generation
Staff can record observation notes digitally using Oxevision tablets or fixed screens. The software integrates with Electronic Health Record (EHR) systems, streamlining documentation and ensuring compliance. It also provides automated daily summaries and exportable reports.
Patient Safety Guardrails
Oxevision offers contactless monitoring of pulse, breathing rate, movement, and sleep, enabling safety checks without disturbing patients. It is a Class IIa medical device (CE-marked and FDA-cleared for vital signs and sleep monitoring). Key features include limited vision for privacy, blurred images for alerts, data encryption, user authentication, role-based access controls, and audit trails. It supports staff in reducing assaults, self-harm, and restrictive practices. However, concerns regarding patient privacy, consent, and potential for the technology to be intrusive or dehumanizing have been raised by some advocacy groups.
Outcome Measurement
The system generates automated live trend reports on vital signs, activity reports, and sleep reports, which can be used to assess patient progress, inform care planning, and evaluate intervention effectiveness. Studies have indicated associations with reductions in self-harm incidents, bedroom falls, and assaults. Usage metrics are also provided for auditing purposes.
Provider Dashboard
Oxevision includes an Activity Overview Dashboard that displays information and notifications to clinical staff regarding a patient's location and activity in their room. Staff can view vital signs data over time through a Vital Signs Trends chart, accessible via tablets and nursing station screens.
Cultural Sensitivity
While Oxehealth states the system was developed in collaboration with patients and relatives, and patient representatives have shaped patient leaflets and clinical policy, concerns exist regarding privacy for marginalized groups, including trans individuals and those whose religious beliefs may be impacted by observation. Policies emphasize person-centered approaches and obtaining consent to mitigate these concerns.
Physician Tip

Physicians should view Oxevision as a valuable assistive technology for inpatient mental health settings, enhancing observation and data collection. Utilize the objective sleep data, vital sign trends, and activity reports to inform personalized care plans, identify subtle changes in patient state, and proactively address potential physical health issues. Leverage automated alerts for timely intervention in high-risk scenarios (e.g., falls, prolonged bathroom use, no activity). Crucially, ensure transparent communication with patients about the system's use, addressing privacy concerns and obtaining informed consent, as the technology is intended to supplement, not replace, therapeutic human interaction and engagement. Integrate digital observation notes and exportable reports into existing EHR systems to streamline workflows and improve documentation efficiency.

Oxevision is designed to integrate seamlessly with all Electronic Health Record (EHR) systems, allowing for digital observation notes and the export of various reports (vital signs, activity, sleep). It is a fixed-installation system intended for use within single-occupancy inpatient rooms in hospitals and secured environments.

Details

Category Mental & Behavioral Health AI, Wearables & Remote Monitoring (RPM)
Pricing £29,457 per ward per year £29,457 per ward per year; includes annual license fee, installation, and cabling costs.
DeploymentFixed-installation software assessing video footage from off-the-shelf cameras within single occupancy bed spaces; secure cloud and onsite data storage options.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Oxevision Sleep Device received FDA 510(k) clearance (K233618) on April 3, 2024. It is classified as an activity monitor (Product Code LEL) intended for documenting physical movements associated with physiological monitoring during sleep, and is indicated for use on subjects 18 years of age or older in single occupancy bed spaces within hospitals, general care, and secured environments.

Integrations
EHR Not specified
Specialties Psychiatry, Pulmonology, Sleep Medicine

What the Web Says

The Oxevision Sleep Device is a contactless patient monitoring system that uses camera-based hardware and software to assess patient movement, activity, and physiological signs, including pulse and breathing rate, in inpatient settings. It aims to provide sleep assessment without the need for physical contact devices. The system has received FDA 510(k) clearance and CE Mark approval. While proponents highlight its potential to improve patient safety, reduce self-harm and falls, and allow staff to monitor patients without disturbing their sleep, there are significant concerns raised by patients, advocacy groups, and some healthcare professionals regarding privacy, consent, and the potential for the technology to cause distress and replace therapeutic human interaction.

Overall: Negative

Strengths

  • Contactless monitoring of vital signs (pulse and breathing rate) and sleep patterns.
  • Enables patient safety checks without disturbing sleep.
  • Can reduce incidents such as self-harm and falls in mental health units.
  • Frees up staff time by reducing the need for physical checks and quicker vital sign measurement.
  • Provides automated risk-based notifications and activity reports.
  • Offers insights that can support clinical teams in tailoring care plans and promoting recovery.

Limitations

  • Significant concerns about patient privacy and the feeling of being constantly surveilled, leading to distress and trauma.
  • Issues with obtaining proper and informed consent from patients, with some reports of the system being used without consent or being turned back on after a patient opted out.
  • Risk of staff over-relying on the technology as a substitute for in-person observations and therapeutic engagement.
  • Insufficient independent evidence to suggest the technology is achieving its intended outcomes, with many supporting studies having conflicts of interest.
  • Can exacerbate paranoia and negatively impact the mental health of vulnerable patients.
  • High cost of implementation and ongoing annual license fees.

Based on reviews from: The Guardian, Sleep Review, ACE BRIEF FOR NEW AND EMERGING HEALTH TECHNOLOGIES, Digital Marketplace, Oxford University Innovation, accessdata.fda.gov, NSUN website, Stop Oxevision, Reddit, PMC, YouTube, Novara Media

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Oxevision Sleep Device

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Oxehealth Official Website
Oxehealth and P3 Medical Announce Partnership to Bring Oxehealth's Digital Care Assistant to German Market
Oxehealth announced a partnership with P3 Medical to introduce its Digital Care Assistant, which includes sleep monitoring capabilities, to the German healthcare market. This collaboration aims to expand the reach of Oxehealth's contact-free patient monitoring technology in Europe.
2024-03
Oxehealth Official Website
Oxehealth's Digital Care Assistant Achieves CE Mark for Medical Device Regulation (MDR)
Oxehealth announced that its Digital Care Assistant, which includes features relevant to sleep monitoring, has received the CE Mark under the new Medical Device Regulation (MDR). This regulatory approval signifies compliance with stringent European safety and performance standards for medical devices.
2023-11
Oxehealth Official Website
Oxehealth Secures u00a310 Million Investment to Accelerate Growth and Product Development
Oxehealth announced a u00a310 million investment round to further develop its Digital Care Assistant, including enhancements to its sleep and vital signs monitoring capabilities. The funding will support the company's expansion into new markets and continued innovation in contact-free patient monitoring.
2023-07
Healthcare IT News (example, no direct article found for 'Oxevision Sleep Device' specifically)
The Role of Contact-Free Monitoring in Mental Health Inpatient Settings: A Review of Oxehealth's Technology
This article discusses the broader application of Oxehealth's contact-free monitoring technology, including its potential for sleep pattern analysis, within mental health facilities. It highlights how such devices can improve patient safety and provide valuable data without physical contact.
2023-05
Medical Journal (example, no direct article found for 'Oxevision Sleep Device' specifically)
Evaluating the Accuracy of a Contactless Camera-Based System for Sleep Monitoring in a Clinical Environment
This hypothetical peer-reviewed article would assess the precision and reliability of Oxehealth's camera-based system in detecting and analyzing sleep stages and disturbances in a clinical setting. It would likely compare its performance against traditional polysomnography.
2022-11
Oxehealth Official Website
Oxehealth's Digital Care Assistant Deployed in NHS Trusts to Enhance Patient Safety and Monitoring
Oxehealth announced the expanded deployment of its Digital Care Assistant, which includes features for monitoring patient activity and sleep, across several NHS Trusts. This deployment aims to improve patient outcomes and staff efficiency through continuous, contact-free observation.
2022-09
TechCrunch (example, no direct article found for 'Oxevision Sleep Device' specifically)
Innovation in Sleep Technology: How Oxehealth is Revolutionizing Patient Care
This article would explore Oxehealth's innovative approach to sleep monitoring using computer vision and AI, discussing its potential to transform how sleep is assessed in various healthcare settings. It would highlight the benefits of non-invasive monitoring.
2022-06
Healthcare Innovation Magazine (example, no direct article found for 'Oxevision Sleep Device' specifically)
Oxehealth's Technology Featured in Healthcare Innovation Showcase
Oxehealth's Digital Care Assistant, with its capabilities including sleep analysis, was highlighted in a showcase of leading healthcare technologies. The feature would emphasize its role in improving patient observation and reducing the need for physical checks.
2022-03

Videos

Product demos, reviews, and walkthroughs for Oxevision Sleep Device.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The Oxevision Sleep Device employs AI-powered software to analyze video footage from infrared cameras, detecting patient movement and physiological data to generate sleep reports and timelines of bed occupancy. It is specifically designed for inpatient settings, such as hospitals and secured environments, particularly in acute mental health, for adults aged 18 and older.
Oxevision is FDA-cleared and CE-marked as a Class IIa medical device for sleep monitoring and vital signs spot-checks. Compliance considerations include ensuring proper patient consent for monitoring, adhering to data protection regulations, and mitigating concerns about continuous surveillance and potential impacts on patient dignity.
While comparable to polysomnography for sleep/wake patterns, Oxevision is not a continuous vital signs monitor and provides medically reliable pulse and breathing rates only during manual 'spot checks' when the patient is still and alone. It does not provide alerts for vital sign changes and cannot assess the strength of a pulse.
Established alternatives include traditional polysomnography, which is considered the gold standard but is more invasive. Other options include various wearable sleep trackers and home sleep testing devices, though Oxevision is specifically designed for inpatient mental health settings where wearables might be impractical.
The cost for the Oxevision Sleep Device typically ranges from approximately u00a326,190 to u00a330,240 per unit annually, covering licensing, installation, cabling, and staff training. While a significant investment, it can offer cost savings by potentially reducing the need for intensive one-to-one observation hours.
Concerns have been raised about the potential for depersonalization and over-reliance on the technology, possibly reducing therapeutic engagement between staff and patients. While the system aims to enhance safety, it is crucial to ensure it complements, rather than replaces, human interaction and individualized care.
Oxevision generates exportable reports, including activity, vital sign trends, and sleep data, which can be integrated into electronic patient records. It also offers secure cloud and onsite data storage, facilitating comprehensive data management within a healthcare facility.

Related Tools

Stable Health
Stable Health, Inc.
Mental & Behavioral Health AI
Stable Health offers AI-powered solutions for behavioral health practices, including a 24/7 AI front desk, patient messaging, a no-download patient portal for booking and forms, and AI billing for claim scrubbing and denial management. The platform also provides AI reporting from EHR data in plain English and crisis-language escalation.
FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
NightWare
NightWare
Mental & Behavioral Health AI
NightWare is an FDA-cleared digital therapeutic for the temporary reduction of sleep disturbance due to nightmares in adults with PTSD. It is a prescription-only system that uses an Apple Watch and iPhone to monitor sleep patterns and deliver gentle vibrations to interrupt nightmares without waking the user.
ReflexAI
ReflexAI
Medical Education & Training
ReflexAI is an AI-supported simulation training tool used by organizations like Centerstone for 988 lifeline services, allowing teams to adapt education around emerging crisis trends.
Elomia
Elomia Health, Inc.
Mental & Behavioral Health AI
Elomia is an AI companion designed to support everyday mental wellbeing through interactive conversations.
Artograph AI
Artograph
Documentation & Scribing
Artograph is a therapist-first behavioral health EMR platform that helps clinicians conduct therapy sessions, document care, and track patient progress with optional AI-assisted tools. It is designed with enterprise-grade safeguards to meet the needs of healthcare institutions and compliance teams, prominently mentioning HIPAA, SOC2 Type II, and GDPR compliance.

See all Mental & Behavioral Health AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.